Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Mechanism BTK inhibitors(Tyrosine-protein kinase BTK inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Systemic Lupus Erythematosus | Preclinical | CN | 06 Aug 2024 | |
Systemic Lupus Erythematosus | Preclinical | CN | 06 Aug 2024 |